Home › NCT06420219

An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Diagnosis/disease status: New diagnosis of head and neck cancer
* Allowable type and amount of prior therapy: No prior treatment
* Age ≥ 18 years.
* Ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria:

* Patients who have had treatment of head and neck cancer

About the study

This study evaluates the cell and biomarkers associated with the aggressive behavior of cancer.

What is being tested

• Non-Interventional Study (other)

Sponsor: University of Southern California · Participants: 50 · Started: Mar 25, 2024

Contact the study team

• Sandy Tran, MS · Phone: 323-865-0451

Official record on ClinicalTrials.gov — NCT06420219

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.